These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 1384634

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Morphological study of cytotoxicity produced by PSK-induced polymorphonuclear leukocytes (PMNs) and Nocardia rubra cell wall skeleton.
    Kata H, Inoue M, Mukai S, Kawahito Y, Yoshida T, Asai K, Kimura S, Hashiramoto A, Yamamura Y, Sano H, Sugino S, Kondo M.
    Biotherapy; 1996; 9(4):229-39. PubMed ID: 9012542
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of rhG-CSF on infection complications and impaired function of neutrophils secondary to chemotherapy for non-Hodgkin's lymphoma. Hokkaido Study Group of Malignant Lymphoma, and rhG-CSF, Japan.
    Kuni-Eda Y, Okabe M, Kurosawa M, Maekawa I, Higuchi M, Kawamura M, Morioka M, Suzuki S, Ohmura T, Fujimoto N.
    Leuk Lymphoma; 1995 Feb; 16(5-6):471-6. PubMed ID: 7540462
    [Abstract] [Full Text] [Related]

  • 8. Purification and characterization of two recombinant human granulocyte colony-stimulating factor glycoforms. Pharmacokinetic and activity studies of single-dose administration in mice.
    Rotondaro L, De Paolis E, Ferrero D, D'Alatri L, Raucci G, Fabbri A, Gerwig GJ, Kamerling JP, Mariani MF, Mele A, De Santis R.
    Mol Biotechnol; 1999 Apr; 11(2):117-28. PubMed ID: 10464766
    [Abstract] [Full Text] [Related]

  • 9. [In-vivo enhancement of neutrophil function by administration of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in cyclophosphamide (CPA) treated mice].
    Yoshida M.
    Nihon Hinyokika Gakkai Zasshi; 1992 Apr; 83(4):518-27. PubMed ID: 1375670
    [Abstract] [Full Text] [Related]

  • 10. Recombinant human granulocyte colony-stimulating factor improves the compromised state of recipient mice without affecting the induction of specific tolerance in the cyclophosphamide-induced tolerance system.
    Nishimura Y, Mayumi H, Tomita Y, Eto M, Maeda T, Nomoto K.
    J Immunol; 1991 Apr 15; 146(8):2639-47. PubMed ID: 1707914
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetic/pharmacodynamic analysis of neutrophil proliferation induced by recombinant granulocyte colony-stimulating factor (rhG-CSF): comparison between intravenous and subcutaneous administration.
    Sugiura M, Yamamoto K, Sawada Y, Iga T.
    Biol Pharm Bull; 1997 Jun 15; 20(6):684-9. PubMed ID: 9212991
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of recombinant human granulocyte-colony stimulating factor on neutropenic mice infected with Candida albicans: acceleration of recovery from neutropenia and potentiation of anti-C. albicans resistance.
    Hamood M, Bluche PF, De Vroey C, Corazza F, Bujan W, Fondu P.
    Mycoses; 1994 Jun 15; 37(3-4):93-9. PubMed ID: 7531290
    [Abstract] [Full Text] [Related]

  • 14. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K, Inoue S, Kumar A.
    Exp Hematol; 1991 Jun 15; 19(5):352-8. PubMed ID: 1709109
    [Abstract] [Full Text] [Related]

  • 15. Neutrophils express the high affinity receptor for IgG (Fc gamma RI, CD64) after in vivo application of recombinant human granulocyte colony-stimulating factor.
    Repp R, Valerius T, Sendler A, Gramatzki M, Iro H, Kalden JR, Platzer E.
    Blood; 1991 Aug 15; 78(4):885-9. PubMed ID: 1714327
    [Abstract] [Full Text] [Related]

  • 16. Experimental study on safety for granulopoiesis in simultaneous therapy with recombinant human granulocyte colony-stimulating factor and chemotherapy.
    Kabaya K, Obuchi M, Watanabe M, Kusaka M, Seki M.
    Oncol Res; 1995 Aug 15; 7(3-4):165-71. PubMed ID: 8555650
    [Abstract] [Full Text] [Related]

  • 17. Enhancement of chemotherapeutic effects by recombinant human granulocyte colony-stimulating factor on implanted mouse bladder cancer cells (MBT-2).
    Akaza H, Fukushima H, Koiso K, Aso Y.
    Cancer; 1992 Feb 15; 69(4):997-1002. PubMed ID: 1370920
    [Abstract] [Full Text] [Related]

  • 18. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis in normal cats.
    Fulton R, Gasper PW, Ogilvie GK, Boone TC, Dornsife RE.
    Exp Hematol; 1991 Sep 15; 19(8):759-67. PubMed ID: 1714401
    [Abstract] [Full Text] [Related]

  • 19. Interleukin-6 production by human neutrophils after Fc-receptor cross-linking or exposure to granulocyte colony-stimulating factor.
    Ericson SG, Zhao Y, Gao H, Miller KL, Gibson LF, Lynch JP, Landreth KS.
    Blood; 1998 Mar 15; 91(6):2099-107. PubMed ID: 9490696
    [Abstract] [Full Text] [Related]

  • 20. Granulocyte kinetics in neutrophilia induced by recombinant human granulocyte colony-stimulating factor in mice.
    Yamagiwa A.
    Fukushima J Med Sci; 1991 Jun 15; 37(1):1-11. PubMed ID: 1725671
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.